Charles River to Sell CDMO, Cell Solutions and European Discovery Assets; Stock Gains Premarket
Charles River Laboratories said it will divest its CDMO and Cell Solutions businesses to GI Partners and certain European Discovery Services assets to IQVIA, triggering a premarket stock increase. The transactions reduce reported revenue for 2026 but are expected to drive at least 100 basis points of non-GAAP operating margin improvement and add ro…